| Dr Rachel Faye Cohen, DO | |
|
12000 E 12 Mile Rd, Warren, MI 48093-3570 | |
| (615) 474-7154 | |
| Not Available |
| Full Name | Dr Rachel Faye Cohen |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 12000 E 12 Mile Rd, Warren, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700443967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5151014063 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Faye Cohen, DO 128 Bowling Ave, Nashville, TN 37205-2340 Ph: (615) 474-7154 | Dr Rachel Faye Cohen, DO 12000 E 12 Mile Rd, Warren, MI 48093-3570 Ph: (615) 474-7154 |
News Archive
"The news that the Central Intelligence Agency had been running a fake vaccination program in Pakistan first surfaced in 2011 and quickly ignited fears that the covert operation could compromise the global campaign to eradicate polio," Lynn Goldman, dean of the George Washington University School of Public Health and Health Services, and Michael Klag, dean of the Johns Hopkins Bloomberg School of Public Health, write in a Baltimore Sun opinion piece, noting a number of polio workers have been killed in the country over the last month.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
A new study in the journal Nature Cell Biology has uncovered information about a key stage that human embryonic cells must pass through just before an embryo implants. The research, led by UCLA biologist Amander Clark, could help explain certain causes of infertility and spontaneous miscarriage.
› Verified 6 days ago
Dr. Edwin V Wehling, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 13355 E 10 Mile Rd, Warren, MI 48089 Phone: 586-759-7300 | |
Martin Quiroga, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 27101 Schoenherr Rd Ste 200, Warren, MI 48088 Phone: 586-806-6466 Fax: 586-806-6395 | |
Dr. Frederick Scott Nichols, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 27472 Schoenherr Rd, Ste #150, Warren, MI 48088 Phone: 586-393-7777 Fax: 586-777-1533 | |
Dr. Zena G Yousif, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 11012 E 13 Mile Rd, Suite 112, Warren, MI 48093 Phone: 586-573-6880 Fax: 586-751-0950 | |
Dr. Jeremy Ryan Ciullo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11012 E 13 Mile Rd Ste 112, Warren, MI 48093 Phone: 586-573-5880 Fax: 586-573-2562 | |
Dr. Anthony A Adeleye, MD Surgery Medicare: Medicare Enrolled Practice Location: 30838 Schoenherr Rd, Warren, MI 48088 Phone: 586-944-2115 Fax: 586-777-1031 | |
John Jerius, MD Surgery Medicare: Medicare Enrolled Practice Location: 27150 Ryan Rd, Warren, MI 48092 Phone: 586-693-3821 |